Get the Stockscreener App
3.98
8.72%
-0.38
After Hours:
4.01
0.03
+0.75%
Clearside Biomedical Inc stock is traded at $3.98, with a volume of 50,783.
It is down -8.72% in the last 24 hours and down -20.06% over the past month.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
See More
Previous Close:
$4.36
Open:
$4.36
24h Volume:
50,783
Relative Volume:
0.58
Market Cap:
$22.82M
Revenue:
$4.17M
Net Income/Loss:
$-27.71M
P/E Ratio:
-10.76
EPS:
-0.37
Net Cash Flow:
$-22.23M
1W Performance:
-8.92%
1M Performance:
-20.06%
6M Performance:
-64.58%
1Y Performance:
-79.90%
1-Day Range:
$3.98
$4.36
1-Week Range:
$3.98
$4.50
52-Week Range:
$3.32
$19.95
Clearside Biomedical Inc Stock (CLSD) Company Profile
Name
Clearside Biomedical Inc
Sector
Industry
Phone
678-270-3631
Address
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Compare CLSD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
3.98 | 22.82M | 4.17M | -27.71M | -22.23M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-18-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-18-25 | Downgrade | Stifel | Buy → Hold |
| Aug-21-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-25-24 | Initiated | Oppenheimer | Outperform |
| Dec-15-21 | Resumed | Wedbush | Outperform |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| May-13-20 | Initiated | ROTH Capital | Buy |
| Aug-09-19 | Downgrade | Needham | Buy → Hold |
| Nov-05-18 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-05-18 | Downgrade | JP Morgan | Overweight → Underweight |
| Nov-05-18 | Downgrade | Stifel | Buy → Hold |
| Mar-06-18 | Reiterated | Needham | Buy |
| May-25-17 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-17 | Initiated | JP Morgan | Overweight |
| Nov-10-16 | Reiterated | Needham | Buy |
| Oct-24-16 | Reiterated | Stifel | Buy |
View All
Clearside Biomedical Inc Stock (CLSD) Latest News
Clearside Biomedical Inc. stock daily chart insightsRisk Management & Daily Risk Controlled Trade Plans - newser.com
Is Clearside Biomedical Inc CLM a good long term investmentInsider Selling Patterns & Low Entry Investment Ideas - earlytimes.in
Will Clearside Biomedical Inc. stock go up soonJuly 2025 Retail & Growth Focused Stock Reports - newser.com
Evaluating Clearside Biomedical Inc. with trendline analysis2025 Bull vs Bear & Smart Money Movement Alerts - newser.com
How institutional ownership impacts Clearside Biomedical Inc. stockMarket Activity Recap & Scalable Portfolio Growth Ideas - newser.com
Clearside Biomedical Regains Nasdaq Compliance as of October 2025 - MSN
What analysts say about Clearside Biomedical Inc CLM stockGrowth Stock Opportunities & Beat the Market with AI Reports - earlytimes.in
Is Clearside Biomedical Inc. meeting your algorithmic filter criteriaJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
Is Clearside Biomedical Inc. (CLM) stock a buy on weaknessPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
Real time breakdown of Clearside Biomedical Inc. stock performance2025 Trading Volume Trends & Community Trade Idea Sharing - newser.com
Using data filters to optimize entry into Clearside Biomedical Inc.Weekly Trend Summary & Community Trade Idea Sharing Platform - newser.com
How Clearside Biomedical Inc. (CLM) stock reacts to stronger dollarTrade Analysis Summary & Free Technical Pattern Based Buy Signals - newser.com
Is a relief rally coming for Clearside Biomedical Inc. holdersInsider Selling & Free Verified High Yield Trade Plans - newser.com
Is Clearside Biomedical Inc. stock poised for growthCEO Change & Long-Term Capital Growth Strategies - newser.com
Earnings visualization tools for Clearside Biomedical Inc.Jobs Report & AI Driven Stock Movement Reports - newser.com
Clearside Biomedical (CLSD) Price Target Increased by 1,400.00% to 64.26 - MSN
Is RR Metalmakers India Limited a Reliable Dividend Payer for Income InvestorsTop Performing Stocks & Free Significant Capital Appreciation - earlytimes.in
Published on: 2025-09-29 15:28:03 - newser.com
Visualizing Clearside Biomedical Inc. stock with heatmapsJuly 2025 Recap & Community Verified Trade Signals - newser.com
Clearside Biomedical Inc Stock (CLSD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clearside Biomedical Inc Stock (CLSD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chong Ngai Hang Victor | Chief Medical Officer |
Nov 01 '24 |
Buy |
1.00 |
36,500 |
36,500 |
100,000 |
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):